3,3-硫代双丙酸双十三酯 | 10595-72-9

• 物质功能分类: 医药中间体 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 3,3-硫代双丙酸双十三酯
• 中文别名: 3,3'-硫代双丙酸双十三烷基酯；硫代二丙酸二(十三酯)；3,3’-硫代双丙酸双十三醇酯；双十三醇硫代二丙酸酯
• 英文名称: Di(tridecyl) thiodipropionate
• 英文别名: tridecyl 3-(3-oxo-3-tridecoxypropyl)sulfanylpropanoate
• CAS: 10595-72-9
• 化学式: C₃₂H₆₂O₄S
• mdl: MFCD00048453
• 分子量: 542.9
• InChiKey: MZHULIWXRDLGRR-UHFFFAOYSA-N

物化性质

• 沸点：
  602.7±40.0 °C(Predicted)
• 密度：
  0.936 g/mL at 25 °C(lit.)
• 闪点：
  >230 °F
• LogP：
  12.935 (est)
• 物理描述：
  Liquid
• 稳定性/保质期：

  如果按照规格使用和储存，则不会分解，未有已知危险发生。

计算性质

• 辛醇/水分配系数(LogP)：
  12.8
• 重原子数：
  37
• 可旋转键数：
  32
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.937
• 拓扑面积：
  77.9
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• WGK Germany：
  1
• 海关编码：
  2930909090

文献信息

• Mixtures composed or monocarboxy-functionalized dialkylphosphinic acids, their use and a process for their preparation
  申请人：Maas Wiebke

  公开号：US20070213436A1

  公开（公告）日：2007-09-13

  The invention relates to mixtures composed of monocarboxy-functionalized dialkylphosphinic acids and of further components, which comprise A) from 98 to 100% by weight of monocarboxy-functionalized dialkylphosphinic acids of the formula (I) in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are identical or different and, independently of one another, are H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, and/or phenyl, X and Y are identical or different and, independently of one another, are H, Li, Na, K, or NH 4 , and B) from 0 to 2% by weight of halogens, where the entirety of the components always amounts to 100% by weight.

  该发明涉及由单羧基功能化二烷基膦酸和进一步组分组成的混合物，其中包括 A) 公式（I）中的单羧基功能化二烷基膦酸，其占98至100重量％ 其中R 1 ，R 2 ，R 3 ，R 4 ，R 5 ，R 6 和R 7 相同或不同，并且彼此独立地为H，甲基，乙基，正丙基，异丙基，正丁基，异丁基，叔丁基和/或苯基， X和Y相同或不同，并且彼此独立地为H，Li，Na，K或NH 4 ， 和 B) 卤素，其占0至2重量％， 其中所有组分的总和始终为100重量％。
• Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components
  申请人：Maas Wiebke

  公开号：US20070210288A1

  公开（公告）日：2007-09-13

  The invention relates to mixtures composed of dialkylphosphinic esters and of further components, which comprise A) from 98 to 100% by weight of monocarboxy-functionalized dialkylphosphinic esters of the formula (I) in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are identical or different and, independently of one another, are H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, and/or phenyl, Y is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, phenyl, 2-hydroxyethyl, 2,3-dihydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 4-hydroxybutyl, 3-hydroxybutyl, 2-hydroxybutyl, and/or 6-hydroxyhexyl, allyl, and/or glycerol, X is H, Li, Na, K or NH 4 , or X is defined as for Y, and then X and Y are two identical radicals or two different radicals of the above organic radicals, and B) from 0 to 2% by weight of halogens, where the entirety of the components always amounts to 100% by weight.

  该发明涉及由二烷基膦酸酯和进一步组分组成的混合物，其中包括A) 公式（I）的单羧基功能化二烷基膦酸酯，其占98至100重量％，其中R1、R2、R3、R4、R5、R6和R7相同或不同，并且独立地为H、甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基和/或苯基，Y为甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、苯基、2-羟乙基、2,3-二羟基丙基、2-羟基丙基、3-羟基丙基、4-羟基丁基、3-羟基丁基、2-羟基丁基和/或6-羟基己基、烯丙基和/或甘油，X为H、Li、Na、K或NH4，或者X如Y所定义，然后X和Y是上述有机基团的两个相同基团或两个不同基团，以及B) 卤素，其占0至2重量％，其中所有组分的总和始终为100重量％。
• [EN] ACRYLATE-FUNCTIONAL BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND COPOLYMER FORMED THEREWITH<br/>[FR] COMPOSÉ D'ORGANOSILICIUM RAMIFIÉ À FONCTION ACRYLATE, SON PROCÉDÉ DE PRÉPARATION ET COPOLYMÈRE FORMÉ AVEC CELUI-CI
  申请人：DOW SILICONES CORP

  公开号：WO2020142474A1

  公开（公告）日：2020-07-09

  A method of preparing an acrylate-functional branched organosilicon compound ("compound") is provided, and comprises reacting (A) a branched organosilicon compound and (B) an acrylate compound in the presence of (C) a catalyst, wherein component (A) has the general formula X-Si(R1)3, where X comprises a halogen-functional moiety and each R1 is selected from R and –OSi(R4)3, with the proviso that at least one R1 is –OSi(R4)3; each R4 is selected from R, –OSi(R5)3, and –[OSiR2]mOSiR3; each R5 is selected from R, –OSi(R6)3, and –[OSiR2]mOSiR3; each R6 is selected from R and –[OSiR2]mOSiR3; each R is an independently selected hydrocarbyl group; and 0≤m≤100; with the proviso that at least one of R4, R5 and R6 is –[OSiR2]mOSiR3. The compound prepared by the method, a copolymer comprising the reaction product of the compound and a second compound, a method of forming the copolymer, and a composition comprising the copolymer are each also provided.

  提供了一种制备丙烯酸酯官能化分支有机硅化合物（“化合物”）的方法，包括在催化剂存在下，使（A）分支有机硅化合物和（B）丙烯酸酯化合物发生反应，其中组分（A）具有一般式X-Si（R1）3，其中X包括卤素官能基，每个R1从R和–OSi（R4）3中选择，但至少一个R1为–OSi（R4）3；每个R4从R、–OSi（R5）3和–[OSiR2]mOSiR3中选择；每个R5从R、–OSi（R6）3和–[OSiR2]mOSiR3中选择；每个R6从R和–[OSiR2]mOSiR3中选择；每个R是独立选择的烃基；且0≤m≤100；但至少一个R4、R5和R6为–[OSiR2]mOSiR3。还提供了通过该方法制备的化合物，包括化合物和第二化合物的反应产物的共聚物，形成共聚物的方法，以及包含共聚物的组合物。
• Organic Silicon-Based Compound And Method Of Producing The Same
  申请人：Kikuchi Taketoshi

  公开号：US20070203275A1

  公开（公告）日：2007-08-30

  Provided are an organic silicon compound of the following formula (I): (wherein, R 1 to R 20 represent each independently alkyl, alkoxy, aryloxy, cycloalkyl, alkylcycloalkyl, aryl, dialkylamino or the like, and the aryloxy and aryl may be substituted with a substituent selected from the group consisting of alkyl, alkoxy and alkoxyalkyl.) which can be used for suppression of coloration and thermal deterioration of an organic material in molding, and an organic material composition containing the organic silicon compound and a method of producing the organic silicon compound.

  提供以下式(I)的有机硅化合物：（其中，R1到R20分别独立表示烷基、烷氧基、芳氧基、环烷基、烷基环烷基、芳基、二烷基氨基或类似物，芳氧基和芳基可被从烷基、烷氧基和烷氧基中选择的取代基所取代。）该化合物可用于抑制有机材料在成型过程中的着色和热降解，以及含有该有机硅化合物的有机材料组合物和生产该有机硅化合物的方法。
• Topical and oral formulations of cardiac glycosides for treating skin diseases
  申请人：Streeper Robert

  公开号：US20060205679A1

  公开（公告）日：2006-09-14

  The present invention provides method, preparation and use of a variety of pharmaceutical compositions containing at least one digitalis glycoside such as oleandrin, odoroside-A, neriifolin, proscillaridin-A, methyl-proscillaridin-A, digitoxin, digoxin alone or at least one digitalis glycoside complexed with cyclodextrins. In another aspect, the present invention provides an effective method to treat diseases in mammals. In yet another aspect, the present invention provides an effective method for treating skin diseases in a human or non-human animal.

  本发明提供了一种方法、制备和使用多种含有至少一种毛地黄苷类药物成分的药物组合物，例如奥利安定、奥多罗苷A、内里福林、普罗斯西拉里丁A、甲基普罗斯西拉里丁A、地高辛、地高辛或至少一种毛地黄苷类与环糊精络合的药物。另一方面，本发明提供了一种有效的方法来治疗哺乳动物的疾病。另一方面，本发明提供了一种有效的方法来治疗人类或非人类动物的皮肤疾病。

表征谱图